6533b7d1fe1ef96bd125cc26

RESEARCH PRODUCT

Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03%

Aikaterini GrigorakiEleni A GeorgakopoulouAntonios PanagiotopoulosPanagiota Loumou

subject

osseodensificationprimary stabilitymedicine.medical_specialtyAdministration TopicalEsthetics DentalTacrolimuslow density boneAtopymedicineHumansGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective StudiesrfaOral Medicine and PathologyClinical pathologybusiness.industryResearchAtopic dermatitisTopical tacrolimusmedicine.diseaseDermatologyLipTacrolimusbody regionsstomatognathic diseasesTreatment OutcomeCheilitisOtorhinolaryngologyConcomitantSurgerybusinessImmunosuppressive Agents

description

Background Exfoliative and erosive cheilitis, may be a source of speech and chewing discomfort, but may also be an aesthetic issue for the patients affected. Such a clinical presentation may implicate a variety of inflammatory conditions, including atopic (eczematous) cheilitis. Topical and systemic agents, e.g. corticosteroids, have been used to treat inflammatory lip conditions. Topical tacrolimus has also been used in some inflammatory lip conditions. Material and Methods We performed a retrospective clinical analysis of atopic cheilitis patients. Results Between 2015 and 2020, we addressed 7 (seven) patients with atopic dermatitis affecting only lips and were diagnosed as atopic-eczematous cheilitis. They were treated with 0.03 per cent topical tacrolimus ointment and responded completely. Conclusions These cases represent an underreported atopy / eczema event;-few cases of atopic cheilitis without concomitant dermal lesions appear in the literature. We are also showing and discussing yet another application of tacrolimus in a local atopic form of inflammation affecting the lips. Key words:Atopy, cheilitis, tacrolimus.

yearjournalcountryeditionlanguage
2020-08-11Medicina Oral Patología Oral y Cirugia Bucal
https://doi.org/10.4317/medoral.24230